Pseudopolymorphic forms of a HIV protease inhibitor

Details for Australian Patent Application No. 2003271740 (hide)

International Classifications

Event Publications

22 January 2004 Complete Application Filed

Priority application(s): 02076929.5 16.05.02 EP

26 February 2004 Application Open to Public Inspection

Published as AU-B-2003271740

13 May 2010 Application Accepted

Published as AU-B-2003271740

9 September 2010 Standard Patent Sealed

5 April 2012 Alteration of Name

The name of the patentee has been altered to Janssen R&D Ireland 2004 Amendments

9 August 2012 Offer to Surrender

Janssen R&D Ireland Eastgate Village Eastgate Little Island , Co Cork , the Patentee of Letters Patent 2003271740 dated 26.08.2010 for an invention titled ' Pseudopolymorphic forms of a HIV protease inhibitor' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender is accepted must lodge a request to be heard within one month from the date of this journal.

18 October 2012 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.